RhumbLine Advisers’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-8,826
| Closed | -$35K | – | 2966 |
|
|
2018
Q4 | $35K | Buy |
8,826
+3,280
| +59% | +$13K | ﹤0.01% | 2963 |
|
|
2018
Q3 | $110K | Buy |
5,546
+1,605
| +41% | +$31.8K | ﹤0.01% | 2853 |
|
|
2018
Q2 | $125K | Buy |
3,941
+1,426
| +57% | +$45.2K | ﹤0.01% | 2846 |
|
|
2018
Q1 | $93K | Buy |
2,515
+478
| +23% | +$17.7K | ﹤0.01% | 2749 |
|
|
2017
Q4 | $161K | Buy |
+2,037
| New | +$161K | ﹤0.01% | 2689 |
|